Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer

Background/AimsThe benefit of second-line chemotherapy (SL) after failed first-line chemotherapy (FL) in patients with advanced pancreatic cancer has not yet been established. We evaluated the clinical characteristics affecting the benefits of SL compared to best supportive care (BSC), identified th...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jeung Eun Lee, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Seungmin Bang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Gastroenterology Council for Gut and Liver 2020-01-01
Edice:	Gut and Liver
Témata:	pancreatic neoplasms second line chemotherapy prognostic model
On-line přístup:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl18419
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!